Dr. Reddy's Laboratories 대차 대조표 상태
재무 상태 기준 확인 6/6
Dr. Reddy's Laboratories 의 총 주주 지분은 ₹309.3B 이고 총 부채는 ₹43.8B, 이는 부채 대 자기자본 비율을 14.2% 로 가져옵니다. 총자산과 총부채는 각각 ₹466.0B 및 ₹156.7B 입니다. Dr. Reddy's Laboratories 의 EBIT는 ₹67.7B 이며 이자보상배율은 -227.8 입니다. ₹63.1B 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보
14.2%
부채 비율
₹43.82b
부채
| 이자 보상 비율 | -227.8x |
| 현금 | ₹63.07b |
| 주식 | ₹309.28b |
| 총 부채 | ₹156.67b |
| 총 자산 | ₹465.96b |
최근 재무 상태 업데이트
Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Oct 14
Dr. Reddy's Laboratories (NSE:DRREDDY) Seems To Use Debt Rather Sparingly
Jul 12Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet
Oct 21Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt
Jul 14Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Apr 11These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well
Jan 10Recent updates
Are Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Investors Paying Above The Intrinsic Value?
Nov 23Dr. Reddy's Laboratories Limited Just Missed EPS By 12%: Here's What Analysts Think Will Happen Next
Nov 08Insufficient Growth At Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Hampers Share Price
Nov 01Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Oct 14If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Aug 19Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models
Aug 01The Market Doesn't Like What It Sees From Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Earnings Yet
Jul 30Dr. Reddy's Laboratories (NSE:DRREDDY) Seems To Use Debt Rather Sparingly
Jul 12Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00
Jun 23Additional Considerations Required While Assessing Dr. Reddy's Laboratories' (NSE:DRREDDY) Strong Earnings
Jun 20Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Dividend Of ₹40.00
May 26Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00
May 10With EPS Growth And More, Dr. Reddy's Laboratories (NSE:DRREDDY) Makes An Interesting Case
May 06There Is A Reason Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Price Is Undemanding
Apr 18Earnings Beat: Dr. Reddy's Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 02Should You Be Adding Dr. Reddy's Laboratories (NSE:DRREDDY) To Your Watchlist Today?
Jan 19Why Investors Shouldn't Be Surprised By Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Low P/E
Jan 01Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet
Oct 21If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Oct 03Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt
Jul 14Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00
Jun 24Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Larger Dividend Than Last Year
Jun 10Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00
May 27Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹40.00
May 13Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Apr 11If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Mar 06These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well
Jan 10If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Dec 05재무 상태 분석
단기부채: DRREDDY 의 단기 자산 ( ₹248.1B )이 단기 부채( ₹129.3B ).
장기 부채: DRREDDY 의 단기 자산( ₹248.1B )이 장기 부채( ₹27.4B ).
부채 대 자본 내역 및 분석
부채 수준: DRREDDY 총 부채보다 더 많은 현금을 보유하고 있습니다.
부채 감소: DRREDDY 의 부채 대 자기자본 비율은 지난 5년간 19.3% 에서 14.2% 로 감소했습니다.
부채 범위: DRREDDY 의 부채는 영업 현금 흐름 ( 77.7% )에 의해 잘 충당되었습니다.
이자 보장: DRREDDY 지불하는 것보다 더 많은 이자를 벌기 때문에 이자 지불 보장은 문제가 되지 않습니다.